down arrow

Biohaven Ltd.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: VGG1110E1079
USD
10.50
-0.5 (-4.55%)

Dec 23

NYS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

10.4611.04

52 Week

7.4844.28
Valuation
Technical
Day's Volume

CASH

748.24 k

Shareholding (Mar 2025)

FII

13.74%

Held by 116 FIIs

DII

50.66%

Held by 44 DIIs

Promoter

1.56%

How big is Biohaven Ltd.?

22-Jun-2025

As of Jun 18, Biohaven Ltd. has a market capitalization of 1,486.76 million, with net sales of 0.00 million and a net profit of -888.59 million over the last four quarters. Shareholder's funds are 423.44 million, and total assets amount to 615.11 million.

As of Jun 18, Biohaven Ltd. has a market capitalization of 1,486.76 million, categorizing it as a Small Cap company.<BR><BR>As of Jun 18, the company reported net sales of 0.00 million for the latest four quarters, with a net profit of -888.59 million during the same period.<BR><BR>As of Dec 24, the reporting period shows shareholder's funds of 423.44 million and total assets amounting to 615.11 million.

Read More

What does Biohaven Ltd. do?

22-Jun-2025

Biohaven Ltd. is a small-cap pharmaceutical and biotechnology company with a market cap of approximately $1.49 billion. As of March 2025, it reported a net profit loss of $222 million and has no dividend yield.

Overview: <BR>Biohaven Ltd. operates in the Pharmaceuticals & Biotechnology industry and is classified as a small-cap company.<BR><BR>Financial Snapshot: <BR>Net Profit: -222 Million (Quarterly Results - Mar 2025) <BR>Market Cap: USD 1,486.76 Million (Small Cap)<BR><BR>Key Metrics: <BR>P/E: NA (Loss Making) <BR>Industry P/E: NA <BR>Dividend Yield: 0.00% <BR>Debt Equity: -1.23 <BR>Return on Equity: -342.43% <BR>Price to Book: 5.73<BR><BR>Contact Details: <BR>Details: No Company Details Available <BR>Registrar Address: Not available.

Read More

Is Biohaven Ltd. technically bullish or bearish?

20-Sep-2025

As of August 15, 2025, Biohaven Ltd. shows a mildly bearish technical trend with mixed signals across indicators, significantly underperforming the S&P 500 with year-to-date and one-year returns of -58.45% and -60.61%, respectively.

As of 15 August 2025, the technical trend for Biohaven Ltd. has changed from bearish to mildly bearish. The weekly MACD indicates a mildly bullish stance, while the monthly MACD remains bearish. The Bollinger Bands show a bullish signal on the weekly timeframe but a mildly bearish signal on the monthly. Daily moving averages are mildly bearish, and the KST is bearish on the weekly. Dow Theory presents a mildly bearish outlook weekly and mildly bullish monthly. The On-Balance Volume is mildly bearish across both timeframes.<BR><BR>In terms of performance, Biohaven has significantly underperformed the S&P 500, with a year-to-date return of -58.45% compared to the S&P's 12.22%, and a one-year return of -60.61% versus the S&P's 17.14%. Overall, the current technical stance is mildly bearish, driven by mixed signals across various indicators.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

USD 1,533 Million ()

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-1.07

stock-summary
Return on Equity

-569.87%

stock-summary
Price to Book

11.39

Revenue and Profits:
Net Sales:
(Quarterly Results - Jun 2025)
Net Profit:
-198 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-25.85%
0%
-25.85%
6 Months
-27.39%
0%
-27.39%
1 Year
-70.95%
0%
-70.95%
2 Years
-73.8%
0%
-73.8%
3 Years
-23.41%
0%
-23.41%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

Biohaven Ltd. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
-52.00%
EBIT to Interest (avg)
-732.47
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-1.23
Sales to Capital Employed (avg)
0
Tax Ratio
0.09%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
6.70
EV to EBIT
-1.54
EV to EBITDA
-1.54
EV to Capital Employed
-23.80
EV to Sales
NA
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-342.43%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
Bullish
Bullish
Bollinger Bands
Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
No Trend
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 75 Schemes (34.03%)

Foreign Institutions

Held by 116 Foreign Institutions (13.74%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Jun 2024",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 38.06% vs -254.15% in Jun 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-210.60",
          "val2": "-332.80",
          "chgp": "36.72%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-198.10",
          "val2": "-319.80",
          "chgp": "38.06%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 0.00% vs 0.00% in Dec 2023",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -107.35% vs 28.42% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-881.20",
          "val2": "-432.70",
          "chgp": "-103.65%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-846.40",
          "val2": "-408.20",
          "chgp": "-107.35%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - YoYstock-summary
Jun'25
Jun'24
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-210.60
-332.80
36.72%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
-198.10
-319.80
38.06%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
USD in Million.
stock-summary Compare with Peers
Net Sales

YoY Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Jun 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Jun 2025 is 38.06% vs -254.15% in Jun 2024

All Quarterly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-881.20
-432.70
-103.65%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
-846.40
-408.20
-107.35%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
USD in Million.
stock-summary Compare with Peers
Net Sales

YoY Growth in year ended Dec 2024 is 0.00% vs 0.00% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -107.35% vs 28.42% in Dec 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Biohaven Ltd. stock-summary
stock-summary
Biohaven Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."